FLR
45
-5
NEM
57
-3
AMGN
31
-5
CTAS
36
8
CPB
39
2
EQIX
59
5
DE
45
-3
GLW
67
2
GE
62
-3
ORLY
48
-2
CMA
68
-2
EXPE
83
2
EMC
60
2
KSS
62
2
NTAP
67
2
XRX
37
-2
VFC
79
2
SLG
39
9
R
76
5
TRIP
60
2
FLR
45
-5
NEM
57
-3
AMGN
31
-5
CTAS
36
8
CPB
39
2
EQIX
59
5
DE
45
-3
GLW
67
2
GE
62
-3
ORLY
48
-2
CMA
68
-2
EXPE
83
2
EMC
60
2
KSS
62
2
NTAP
67
2
XRX
37
-2
VFC
79
2
SLG
39
9
R
76
5
TRIP
60
2
Financhill
Back

Hi-Lex Corp. 10K Form

Sell
13

HLXFF
Hi-Lex Corp.

Last Price:
$7.82
Seasonality Move:
0%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive HLXFF News And Ratings

See the #1 stock for the next 7 days that we like better than HLXFF

HLXFF Financial Statistics

Sales & Book Value

Annual Sales: $2.1B
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $30.77
Price / Book: 0.25

Profitability

EPS (TTM): 0.25450
Net Income (TTM): $18.4M
Gross Margin: $205.9M
Return on Equity: 1.45%
Return on Assets: 1%

Hi-Lex Corp. Earnings Forecast

Key Hi-Lex Corp. Financial Ratios

  • The Gross Profit Margin over the past 20 years for HLXFF is 10.04%.
  • The Selling, General & Administrative Expenses for HLXFF have been equal to 9.92% of Gross Profit Margin.
  • The Research & Development expenses have been 1.46% of Revenue.
  • The Interest Expense is 12.78% of Operating Income.
  • The Net Earning history of HLXFF is 1.15% of Total Revenues.
  • Per Share Earnings over the last 20 years have been positive in 9 years.

Hi-Lex Corp. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Automobile Components
Sector: Consumer Discretionary
Current Symbol: HLXFF
Website: hi-lex.co.jp

Debt

Debt-to-Equity Ratio: 0.05
Current Ratio: 2.26
Quick Ratio: 1.57

Price-to-Earnings

Trailing P/E Ratio: 22.37
Forward P/E Ratio: 0

HLXFF Technical Analysis vs Fundamental Analysis

Sell
13
Hi-Lex Corp. (HLXFF) is a Sell

Is Hi-Lex Corp. a Buy or a Sell?

  • Hi-Lex Corp. stock is rated a Sell
    The current Hi-Lex Corp. [HLXFF] share price is $7.82. The Score for HLXFF is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.